Skip to main content
. 2020 Jun 22;14(Suppl 9):8. doi: 10.1186/s12919-020-00192-2

Table 2.

Potentially preventable fraction of HPV-associated cancers in Colombia with currently available HPV vaccines

Anatomic Site No. HPV DNA+ HPV DNA+ Bivalent (2-valent) or quadrivalent (4-valent) Vaccines HPVDNA + Nonavalent (9-valent) Vaccine
ANUS 39 94.9% 81.1% 100.0%
CERVIX 841 78.4% 67.5% 87.7%
HEAD & NECK 192 26.0% 80.0% 88.0%
PENIS 54 50.0% 70.4% 85.2%
VAGINA 29 72.4% 47.6% 85.7%
VULVA 48 60% 79% 86%

*Based on HPV+ cases

Source: Hernandez-Suarez G, Muñoz, N et al. unpublished results